LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

LLY

885.74

+0.89%↑

JNJ

242.36

+0.87%↑

ABBV

213.05

+1.61%↑

NVS

150.35

+1.42%↑

MRK

117.86

-1.52%↓

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

860.88 0.12

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

854.11

Max

869.8

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

25.318

57.05

Dividendenrendite

0.35

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+15.24% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.35%

2.52%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

1. Juni 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

3B

108B

Vorheriger Eröffnungskurs

860.76

Vorheriger Schlusskurs

860.88

Nachrichtenstimmung

By Acuity

43%

57%

26 / 349 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

30. März 2026, 23:15 UTC

Wichtige Nachrichtenereignisse

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30. März 2026, 22:36 UTC

Wichtige Nachrichtenereignisse

Australian Government Rules Out Boots on the Ground in the Middle East

30. März 2026, 22:13 UTC

Akquisitionen, Fusionen, Übernahmen

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30. März 2026, 21:00 UTC

Ergebnisse

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30. März 2026, 20:15 UTC

Wichtige Nachrichtenereignisse

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30. März 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. März 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30. März 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30. März 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30. März 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30. März 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30. März 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30. März 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30. März 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30. März 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30. März 2026, 21:58 UTC

Akquisitionen, Fusionen, Übernahmen

Sun Life Financial Agrees to Buy Bell Partners for $350M

30. März 2026, 21:39 UTC

Akquisitionen, Fusionen, Übernahmen

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30. März 2026, 21:38 UTC

Akquisitionen, Fusionen, Übernahmen

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30. März 2026, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30. März 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30. März 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. März 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30. März 2026, 21:03 UTC

Akquisitionen, Fusionen, Übernahmen

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30. März 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. März 2026, 20:09 UTC

Ergebnisse

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30. März 2026, 20:00 UTC

Wichtige Nachrichtenereignisse

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

15.24% Vorteil

12-Monats-Prognose

Durchschnitt 991.22 USD  15.24%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

26 / 349 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat